1. Introduction

This is a preview lesson
Purchase this course, or sign in if you’re already enrolled, to take this lesson.

The Skin Course

Release date: December 09, 2021

Expiration date: December 09, 2025

Estimated time to complete activity: 15.0 hours

Jointly provided by Postgraduate Institute for Medicine and WhiteCoat Education Group, LLC.

Target Audience

This activity is intended for registered nurse practitioners and physician assistants engaged in the care of patients with dermatological complaints and disease states.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Recognize the most common dermatologic diseases.
  • Identify treatment measures according to the standard of care.
  • Employ those measures.
  • Evaluate the efficacy of those measures.
  • Manage patient response to treatment measures.


Patton D. Graham, NP-C

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and WhiteCoat Education Group, LLC.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 15.0 contact hours. Designated for 10.0 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

Continuing Physician Assistants Education

The Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 15.0 AAPA Category 1 CME credits. Approval is valid until December 09, 2023. PAs should only claim credit commensurate with the extent of their participation.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


The faculty members have nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The WhiteCoat Education Group, LLC. planners and managers have nothing to disclose.

Method of Participation and Request for Credit

Post-activity quiz and evaluation



Computer System Requirements

Internet connection using Microsoft Edge, Apple Safari, or Google Chrome.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.